Get started
PHARMANUTRA S.P.A.PHARMANUTRA S.P.A.PHARMANUTRA S.P.A.

PHARMANUTRA S.P.A.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

761 chart


Full chart

761 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪476.79 M‬ EUR
Dividend yield (indicated)
2.03%
Price to earnings Ratio (TTM)
28.05
Basic EPS (TTM)
1.75 EUR
Net income (FY)
‪16.61 M‬ EUR
Revenue (FY)
‪115.50 M‬ EUR
Shares float
‪3.12 M‬
Beta (1Y)
0.44

Employees


Employees (FY)
118
Change (1Y)
+13 +12.38%
Revenue / Employee (1Y)
‪978.80 K‬ EUR
Net income / Employee (1Y)
‪140.75 K‬ EUR

About PHARMANUTRA


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Andrea Lacorte
Website
pharmanutra.it
Headquarters
Pisa
Founded
2003
ISIN
IT0005274094
FIGI
BBG00YQ79323
Pharmanutra SpA develops nutraceutical products and medical devices. Its Sroscaloidal Iron intends to restore articular and movement ability in osteoarticular affections, consisting of cetilar line. The company was founded by Andrea Lacorte and Roberto Lacorte in 2003 and is headquartered in Pisa, Italy.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

761 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 761.

Frequently Asked Questions


The current price of 761 is 48.50 EUR — it has increased by 3.09% in the past 24 hours. Watch PHARMANUTRA S.P.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PHARMANUTRA S.P.A. stocks are traded under the ticker 761.
761 stock has risen by 2.04% compared to the previous week, the month change is a −9.26% fall, over the last year PHARMANUTRA S.P.A. has showed a −15.06% decrease.
We've gathered analysts' opinions on PHARMANUTRA S.P.A. future price: according to them, 761 price has a max estimate of 88.00 EUR and a min estimate of 74.00 EUR. Watch 761 chart and read a more detailed PHARMANUTRA S.P.A. stock forecast: see what analysts think of PHARMANUTRA S.P.A. and suggest that you do with its stocks.
761 reached its all-time high on Jan 10, 2022 with the price of 78.60 EUR, and its all-time low was 34.70 EUR and was reached on Jan 12, 2021. View more price dynamics on 761 chart.
See other stocks reaching their highest and lowest prices.
761 stock is 3.09% volatile and has beta coefficient of 0.44. Track PHARMANUTRA S.P.A. stock price on the chart and check out the list of the most volatile stocks — is PHARMANUTRA S.P.A. there?
Today PHARMANUTRA S.P.A. has the market capitalization of ‪472.96 M‬, it has decreased by −8.70% over the last week.
Yes, you can track PHARMANUTRA S.P.A. financials in yearly and quarterly reports right on TradingView.
PHARMANUTRA S.P.A. is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
761 net income for the last quarter is ‪3.44 M‬ EUR, while the quarter before that showed ‪4.27 M‬ EUR of net income which accounts for −19.52% change. Track more PHARMANUTRA S.P.A. financial stats to get the full picture.
Yes, 761 dividends are paid annually. The last dividend per share was 0.85 EUR. As of today, Dividend Yield (TTM)% is 1.73%. Tracking PHARMANUTRA S.P.A. dividends might help you take more informed decisions.
As of Mar 31, 2025, the company has 118 employees. See our rating of the largest employees — is PHARMANUTRA S.P.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMANUTRA S.P.A. EBITDA is ‪30.23 M‬ EUR, and current EBITDA margin is 26.11%. See more stats in PHARMANUTRA S.P.A. financial statements.
Like other stocks, 761 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMANUTRA S.P.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMANUTRA S.P.A. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMANUTRA S.P.A. stock shows the strong sell signal. See more of PHARMANUTRA S.P.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.